Douglas Yee
Professor of Medicine and Pharmacology · University of Minnesota
Credentials: · · · ·
History
- Present
- 1984–1986
Medical Oncology
- 1981–1984
Internal Medicine
Research
Diabetes and cancer: a consensus report
Diabetes Care · 2010 · Last of 9 authors · 1,589 citations
APOBEC3B is an enzymatic source of mutation in breast cancer
Nature · 2013 · 719 citations
JAMA Oncology · 2020 · 610 citations
51 papers
42 papers
34 papers
31 papers
31 papers
26 papers · 4 as a resident
26 papers
25 papers
Grants
- 2020–2031
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer
National Cancer Institute · R01
PI · $652.4K · University of Minnesota
- 2019–2030
National Cancer Institute · P01
PI · $10.7M · University of Texas Hlth Science Center
- 1998–2029
National Cancer Institute · P30
Contact PI · $67.5M · University of Minnesota
- 2020–2025
Disrupting Insulin Receptor Function in Breast Cancer
National Cancer Institute · R01
Contact PI · $1.7M · University of Minnesota
Clinical trials
- 2008–2014
Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca
Principal investigator · Terminated · Phase 2
Masonic Cancer Center, University of Minnesota
- 2008–2009
Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
Principal investigator · Withdrawn · Phase 2
Masonic Cancer Center, University of Minnesota
- 2006–2013
Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
Principal investigator · Terminated · Phase 2
Masonic Cancer Center, University of Minnesota
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
Principal investigator · Withdrawn · Phase 1
Pfizer